Abstract:Introduction: Keloids and hypertrophic scars are fibroproliferative disorders of the skin that result from abnormal healing of injured or irritated skin. Multiple studies suggest that genetic, systemic and local factors may contribute to the development and/or growth of keloids and hypertrophic scars. A key local factor may be mechanical stimuli. Here, we provide an up-to-date review of the studies on the roles that genetic variation, epigenetic modifications and mechanotransduction play in keloidogenesis. Methods: An English literature review was performed by searching the PubMed, Embase and Web of Science databases with the following keywords: genome-wide association study; epigenetics; non-coding RNA; microRNA; long non-coding RNA (lncRNA); DNA methylation; mechanobiology; and keloid. The searches targeted the time period between the date of database inception and July 2018. Results: Genetic studies identified several single-nucleotide polymorphisms and gene linkages that may contribute to keloid pathogenesis. Epigenetic modifications caused by non-coding RNAs (e.g. microRNAs and lncRNAs) and DNA methylation may also play important roles by inducing the persistent activation of keloidal fibroblasts. Mechanical forces and the ensuing cellular mechanotransduction may also influence the degree of scar formation, scar contracture and the formation/progression of keloids and hypertrophic scars. Conclusions: Recent research indicates that the formation/growth of keloids and hypertrophic scars associate clearly with genetic, epigenetic, systemic and local risk factors, particularly skin tension around scars. Further research into scar-related genetics, epigenetics and mechanobiology may reveal molecular, cellular or tissue-level targets that could lead to the development of more effective prophylactic and therapeutic strategies for wounds/scars in the future.

[Advances in the Research of the Effect of Toll-Like Receptor in the Formation of Keloid].

Research advances on inflammatory responses involved in keloid development

The effect of TLR4/7 on the TGF-β-induced Smad signal transduction pathway in human keloid.

Research development in the pathogenic mechanism of keloids

The effects of systemic diseases, genetic disorders and lifestyle on keloids

Keloid research: current status and future directions

Epigenetic modification mechanisms involved in keloid: current status and prospect

Keloidal Pathophysiology: Current Notions.

Progress in Drug Treatment of Keloid

Emerging Roles of Long Non-Coding RNAs in Keloids.

HIF-1α Promotes the Keloid Development Through the Activation of TGF-β/Smad and TLR4/MyD88/NF-κB Pathways.

Comprehensive Modular Analyses of Scar Subtypes Illuminate Underlying Molecular Mechanisms and Potential Therapeutic Targets.

[Examining the Pathogenesis and Therapeutic Strategy of Keloids from the Perspective of Systemic Inflammation].

Comprehensive Insights into Keloid Pathogenesis and Advanced Therapeutic Strategies

Biomechanical Regulatory Factors and Therapeutic Targets in Keloid Fibrosis

Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation

Detection and Analysis of Long Noncoding RNA Expression Profiles Related to Epithelial-Mesenchymal Transition in Keloids

Important role of mechanical microenvironment on macrophage dysfunction during keloid pathogenesis

Quantitative proteomics approach reveals novel biomarkers and pathological mechanism of keloid

Roles of Lipid Metabolism in Keloid Development

Metabolism, fibrosis, and apoptosis: The effect of lipids and their derivatives on keloid formation